Related by context. All words. (Click for frequent words.) 75 ml min 71 CrCl 70 creatinine clearance 65 pg mL 65 ng dL 65 ng mL 64 mL/min/#.# m 2 64 mL sec 63 mild renal impairment 63 mm Hg systolic 63 mcg mL 63 μmol L 63 pmol L 62 pg ml 62 #mmHg [001] 62 nmol L 62 μg L 62 mEq L 62 mmHg 62 mL kg 62 mg d 61 mL/min/#.# m2 61 alanine aminotransferase 61 Serum creatinine 61 nmol liter 61 mcg BID 61 #mg/dL [001] 60 kg -1 60 aspartate aminotransferase AST 60 systolic dysfunction 60 eGFR 60 mmol L 60 mg dL 60 mU liter 60 mmol l 60 g dl 60 mIU L 60 mm Hg 60 estimated glomerular filtration 60 min -1 59 QRS width 59 μg mL 59 ng ml 59 g dL 59 nmol 59 FEV1 59 lispro 59 moderate renal impairment 59 creatinine ratio 59 glomerular filtration rate 59 mm Hg diastolic 59 left ventricular systolic 59 aspartate aminotransferase 59 aminotransferases 59 QTcF 59 ejection fractions 59 PSA nadir 59 macroalbuminuria 59 P = .# 59 #.#mg/dL 59 fraction LVEF 59 LVEF 59 normal ULN 59 mmHg diastolic 59 serum potassium 59 #.#/#.# mm Hg [003] 58 nondiabetic patients 58 per deciliter mg 58 crossclamp 58 ug ml 58 x ULN 58 CK MB 58 PaO 2 58 MADRS score 58 sUA 58 kg/m2 58 serum creatinine 58 mIU ml 58 kPa 58 Left Ventricular Ejection Fraction 58 IIIa inhibitors 58 Hb A1C 58 serum phosphorus 58 mmHg systolic 58 SCr 58 ALT elevation 58 severe renal impairment 57 lpm 57 μg kg 57 serum concentrations 57 umol L 57 mU L 57 fasting triglyceride levels 57 IU ml 57 mg dl 57 ischemia driven 57 serum sodium 57 uM 57 mild renal insufficiency 57 mm3 57 serum testosterone 57 ml kg 57 bypass grafting 57 microg 57 certolizumab 57 leukocyte count 57 pulmonary capillary wedge 57 fractional shortening 57 hepatic enzymes 57 #mmHg [002] 57 ug kg 57 glomerular filtration 57 SGPT 57 cm H2O 57 -#.# mg dL [002] 57 transaminases 57 #mg/kg [002] 57 diastolic BP 57 Cmax 57 tirofiban 56 % CI #.#-#.# [001] 56 serum uric acid 56 binary restenosis 56 #mg/dL [002] 56 EDSS score 56 mcg kg 56 #.#-#.# [011] 56 NIHSS 56 pmol liter 56 AUC0 56 alanine aminotransferase ALT 56 % Confidence Interval 56 nicardipine 56 serum creatinine levels 56 LV ejection fraction 56 ug mL 56 #μg [001] 56 #mm Hg 56 nondiabetics 56 left ventricular dysfunction 56 #mg/day [001] 56 scfm 56 lopinavir r arm 56 serum urate levels 56 MACCE 56 mg QD 56 adjunctive placebo 56 intact parathyroid hormone 56 serum urate 56 pT3 56 μg ml 56 -#.# mmHg 56 CsA 56 intravesical therapy 56 g cm 56 mU 56 euthyroid 56 creatine kinase MB 56 ejection fraction 56 thromboembolic events 56 placebo p = 56 cGy 55 ropivacaine 55 confidence interval CI 55 baseline HbA1c 55 NYHA Class II 55 plasma uric acid 55 μl 55 primary hypercholesterolemia 55 μg 55 pulmonary arterial 55 mL 55 β blocker 55 serum phosphate levels 55 % CI #.#-#.# [004] 55 log# copies mL 55 mmol 55 severe neutropenia 55 highest tertile 55 serum aminotransferase levels 55 IIIa inhibitor 55 mg TID 55 fluticasone salmeterol 55 MBq 55 creatinine 55 4mg/kg 55 glycoprotein IIb IIIa inhibitors 55 μg liter 55 gastric pH 55 hemodynamically significant 55 NNT = 55 serum IGF 55 adjunctive ABILIFY 55 #ng/ml 55 Î ¼ 55 serum HBV DNA 55 χ 55 reintubation 55 AST ALT 55 baseline serum creatinine 55 serum prostate 55 alanine transaminase 55 #.#/#.# mmHg [001] 55 #.#ng/ml 55 systemic embolism 55 lumbar spine BMD 55 hypertensives 55 TAXUS Express Stent 55 non valvular atrial 55 rizatriptan 55 NPH insulin 55 mcg QD 55 confidence intervals CIs 55 hypogonadal men 55 statin monotherapy 54 Complication rates 54 hepatorenal syndrome 54 mcg ml 54 aminotransferase elevations greater 54 TAXUS p value 54 mH 54 hemoglobin A1c levels 54 platelet inhibition 54 mCi kg 54 specific antigen PSA 54 CDAI score 54 serum ALT 54 daunorubicin 54 neutrophil counts 54 #mg/dl 54 msec 54 mEq 54 candesartan cilexetil 54 advanced adenomas 54 abciximab 54 hypophosphatemia 54 lactate dehydrogenase 54 receiving prophylactic anticoagulation 54 BMS p = 54 intima media thickness 54 glulisine 54 serum magnesium 54 ertapenem 54 hypopneas 54 budesonide pMDI 54 mbar 54 IU mL 54 serum potassium levels 54 hours postdose 54 -#.# ± [002] 54 #OHD 54 glycated hemoglobin 54 pulmonary exacerbations 54 CK # plasma concentrations 54 mg BID 54 transferrin saturation 54 deferoxamine 54 ng dl 54 saline placebo 54 detrusor 54 hyperkalemia 54 Quiescent current 54 p = .# [002] 54 ipsilateral stroke 54 glycated hemoglobin levels 54 ± #.#mm [001] 54 NYHA Class III 54 milliliter ng ml 54 saphenous vein grafts 54 baseline FEV 54 troponin T 54 serum ferritin 54 cTnI 54 ≥ 54 preserved ejection fraction 54 interquartile range 54 left ventricular ejection 54 normothermic 54 aminotransferase levels 54 Mg Uk 54 Index CDAI 54 SUVmax 54 oral allopurinol 54 -#.# ± [001] 54 serum calcium 54 urine albumin 54 plus GP IIb 54 #.#mmol L [002] 54 anemia hemoglobin 54 hypokalemia 54 systolic blood pressures 54 g l 54 renal dysfunction 54 osmolality 54 albumin excretion 54 micromolar 54 BENICAR HCT 54 lumbar spine bone 54 oral antidiabetic medication 54 5-FU/LV 54 systemic hypotension 54 left ventricular hypertrophy 54 plasma concentrations 54 plasma concentration Cmax 54 nonobese 54 antihypertensive medications 54 euvolemic 54 concentration Cmax 54 statistical significance p 54 indinavir 54 undetectable HCV RNA 54 thromboembolic complications 54 cTnT 54 HBeAg seroconversion 54 % CI #.#-#.# [003] 54 SGOT 54 mu g 54 nadolol 53 stenoses 53 chlorambucil 53 plasminogen activator inhibitor 53 mg/m2/day 53 insulin detemir 53 nonfasting triglyceride levels 53 ^ sup -1 53 mmol L. 53 QTc 53 serum sodium concentration 53 AUCs 53 coronary stenosis 53 mcg kg min 53 alteplase 53 abacavir lamivudine 53 #/#mmHg 53 Peg IFN 53 virologic failure 53 thyroglobulin 53 mIU mL 53 oxycodone IR 53 diabetes mellitus DM 53 Mg Usa 53 μg l 53 microliter 53 atorvastatin #mg 53 μmol 53 kg m² 53 mol L 53 adiponectin concentrations 53 antihypertensive therapy 53 nmol L. 53 PASI scores 53 1ppm 53 lactate dehydrogenase LDH 53 % CI #.#-#.# [007] 53 HbA1c levels 53 iPTH 53 overt nephropathy 53 X ULN 53 albumin excretion rate 53 mg kg hr 53 triglyceride TG 53 ventricular ejection fraction 53 serum phosphate 53 arteriolar 53 serum cortisol 53 mCi 53 biochemical recurrence 53 hypovolemic 53 urinary albumin 53 isoenzyme 53 cholesterol LDL C 53 proteinuria 53 LANTUS R 53 preoperative PSA 53 microlitres 53 arterial thromboembolic events 53 octreotide LAR 53 benazepril 53 hemoglobin Hb 53 Diastolic 53 LDL C 53 renal impairment 53 log# IU mL 53 cardiac troponin T 53 μg dL 53 serum phosphorous 53 lymphocytosis 53 mg eq 53 milliliter ng mL 53 -#.# log# 53 placebo p 53 copies mL 53 peptide BNP 53 expiratory 53 p ≤ 53 systemic corticosteroids 53 creatinine levels 53 serum triglycerides 53 MELD scores 53 urinary albumin excretion 53 QRS duration 53 typ. 53 nanograms per 53 subtrochanteric 53 leukopenia 53 nondiabetic 53 microgram kg 53 Creatinine 53 stent binary restenosis 53 periprocedural 53 contractile function 53 HOMA IR 53 retransplantation 53 #.#mmol l [002] 53 LAB GHRH 53 undergoing coronary artery 53 nM 53 p = NS 53 generalized edema 53 pmol 53 SHBG levels 53 BMI ≥ 53 p = #.# [002] 53 concomitant medications 53 CI #.#-#.# [001] 53 PREZISTA ritonavir 53 detrusor overactivity 53 metformin monotherapy 53 ULORIC 53 XIENCE V PROMUS Stent 53 Non inferiority 53 valvular disease 53 triglycerides TG 53 AVODART 53 nanomoles per 53 paricalcitol 53 microalbuminuria 53 IOP lowering 53 terfenadine 53 thyrotropin 53 rapid virological response 53 reduce serum phosphate 52 severe renal insufficiency 52 mediated dilation 52 everolimus eluting stents 52 PSADT 52 mg kg dose 52 m ^ sup 52 serum transaminases 52 % CI #.#-#.# [002] 52 cm2 52 unfractionated heparin UFH 52 % CI #.#-#.# [006] 52 isolated systolic hypertension 52 oxyhemoglobin 52 endometrial thickness 52 intraocular pressure IOP 52 μS cm 52 receiving VICTRELIS 52 aminotransferase ALT 52 nmol l 52 PLX STROKE targeting 52 normotensive 52 biochemical relapse 52 hydroxyvitamin D levels 52 iobenguane 52 GP IIb IIIa 52 potent CYP#A# inhibitors 52 HbA 1c 52 bosentan 52 urate lowering therapy 52 β blockers 52 #mg BID [003] 52 pericardial effusion 52 serum albumin 52 deep venous thromboses 52 1g t Au 52 recurrent VTE 52 eplerenone 52 microlitre 52 ìg 52 #μg [002] 52 DAS# [002] 52 μL 52 Fasting blood glucose 52 Bulk density 52 MIC# [001] 52 #ppm U 52 hs CRP 52 cells uL 52 REYATAZ r arm 52 BENICAR 52 psig 52 bioavailable testosterone 52 Hb A1c 52 HBeAg negative 52 asymptomatic carotid stenosis 52 degC 52 Ncm 52 cells mcL 52 mg hydrochlorothiazide 52 Â ± 52 estimated GFR 52 #,#-#,# ft. Loc 52 beclomethasone dipropionate 52 dysfunction LVSD 52 #mg/day [002] 52 NYHA class 52 reintervention 52 corticosteroid dose 52 n = 52 mg dose 52 placebo PBO 52 #.#mmHg 52 ALT flares 52 #mg/m# [001] 52 sinus tachycardia 52 ara C 52 TMC# r 52 #mg #mg #mg [003] 52 hypoxemia 52 transaminase elevations greater 52 bezafibrate 52 Hazard Ratio HR 52 receiving ISENTRESS 52 rFVIIa 52 achieved ACR# 52 Taxus Stent 52 Nephrol 52 systolic BP 52 lopinavir r 52 aplastic anemia AA 52 COZAAR 52 amprenavir 52 anastomotic leak 52 MULTAQ 52 primary aldosteronism 52 WIDTH 52 confidence interval #.#-#.# 52 colorectal adenoma 52 albuminuria 52 transaminase 52 CI -#.# 52 annualized relapse 52 nanomolar 52 occlusive disease 52 bronchodilation 52 protein excretion 52 primary percutaneous coronary 52 HbA 1c levels 52 #.#mL 52 microliters 52 stenotic 52 mg tid 52 irbesartan 52 m³ h 52 p = #.# [003] 52 inotropic agents 52 NATRECOR R 52 Intracranial 52 diastolic hypertension 52 femtogram 52 cerebrovascular events 52 Acetate Rectal Suppositories 52 elevated ALT 52 Endothelial dysfunction 52 neostigmine 52 interferon alfa 2b 52 -Osmanli 52 curve AUC 52 ARB telmisartan 52 Apidra ® 52 sirolimus eluting stent 52 tHcy 52 kg hr 52 paroxysmal AF 52 ventricular dilatation 52 PSIG 52 carotid stenosis 52 micromoles 52 #ppb [003] 52 HAM D# scores 52 coronary revascularization 52 subclinical hypothyroidism 52 diastolic blood pressures 52 quetiapine risperidone 52 unfractionated heparin 52 detemir 52 inotropic 52 mg m² 52 elevated serum creatinine 52 systolic hypertension 52 ACE inhibitor ramipril 52 Fasting plasma glucose 52 RNA copies mL 52 chemoradiation therapy 52 μg d 52 nonobstructive CAD 52 mg mL 52 TEAEs 52 serum phosphorus levels 52 microvolts 52 TURBT 52 mg/m2 dose 52 IV NSCLC 52 postoperatively 52 picogram 52 μg g 52 atherosclerotic renal artery stenosis 52 RYGB 52 preserved systolic 52 μV 52 elevated IOP 52 GnRH agonist 51 serum lactate 51 transaminase elevations 51 IFN α 51 hyperoxia 51 steroid dexamethasone 51 μW 51 CCyR 51 angiotensin converting enzyme inhibitor 51 bone marrow reticulin 51 -#.# log# copies mL 51 plus prednisone prednisolone 51 sirolimus stent 51 baseline neutrophil counts 51 A1C levels 51 Median survival 51 dizziness nausea diarrhea 51 infliximab monotherapy 51 overt hypothyroidism 51 anovulatory 51 apnea hypopnea index 51 thromboembolic 51 noncardiac 51 PROCTOCORT ® Suppository Hydrocortisone 51 renal function 51 plus glycoprotein IIb 51 dysuria 51 fibrinolysis 51 bivalirudin monotherapy 51 p = 51 ULN 51 cardiac ischemia 51 T2DM 51 8mg/kg 51 t/m3 51 superficial femoral 51 mg kg 51 atheroma volume 51 VAPRISOL 51 Sustained virologic response 51 systemic corticosteroid 51 NYHA functional class 51 NIHSS score 51 hypogonadal 51 echocardiographic parameters 51 Cypher Stent 51 diastolic heart 51 elevated transaminases 51 psia 51 EBRT 51 deciliter 51 tolterodine ER 51 mcg dL 51 hyperphenylalaninemia HPA due 51 Hypotension 51 #.#ml [002] 51 occluded catheters 51 rs# [004] 51 Am J Cardiol 51 hemoglobin A1c HbA1c 51 advanced neoplasia 51 gadolinium enhancing 51 l h 51 Intraocular pressure 51 hour bronchodilation 51 sUA levels 51 phonophobia 51 mean baseline HbA1c 51 corrected QT interval 51 aortic root replacement 51 hypoperfusion 51 definite stent thrombosis 51 epoprostenol 51 IM progesterone 51 arterial oxygen saturation 51 transaminase levels 51 transthoracic 51 test OGTT 51 ± 51 mRNA expression 51 pneumonectomy 51 non splenectomized 51 clodronate 51 MMscf 51 percutaneous intervention 51 IPSS 51 transurethral resection 51 ug L 51 foveal thickness 51 milliliters mL 51 extrapyramidal symptoms 51 NSTE ACS 51 cerebrovascular accident 51 hip BMD 51 zonisamide SR 51 #mg doses [002] 51 noninferior 51 cystectomy 51 A1c levels 51 beta blocker therapy 51 bacteriuria 51 NovoLog ® Mix 51 evaluable subjects 51 Plasma concentrations 51 #mg dose [003] 51 pulsatile flow 51 Thrombolysis 51 INVEGA ® 51 comparator arm 51 CHD mortality 51 salmeterol fluticasone 51 micrograms mL 51 glycosylated hemoglobin HbA1c 51 urolithiasis 51 elevated hsCRP 51 sitosterol 51 Cream USP 1 51 tapentadol ER 51 log# 51 nonischemic 51 transcranial Doppler 51 #.#mg/kg [002] 51 severe exacerbations 51 tamsulosin 51 oral levofloxacin 51 tissue plasminogen activator tPA 51 advanced adenoma 51 mcg 51 creatine phosphokinase 51 hydroxyvitamin D 51 glimepiride 51 bypass graft CABG surgery 51 biphasic insulin aspart 51 graft occlusion 51 mmHg p = 51 serum bilirubin 51 lowest tertile 51 HBeAg positive 51 arteriovenous fistula 51 pulsatility index 51 serum triglyceride levels 51 plasma glucose levels 51 elevated creatinine 51 diastolic pressures 51 #mV V 51 vasopressor 51 oxycodone CR 51 Expanded Disability Status 51 cardiovascular hospitalizations 51 lymphadenectomy 51 intrahepatic 51 bolus dose 51 primary patency 51 cm3 51 typical antipsychotics 51 3mg 51 hepatic enzyme 51 leucopenia 51 serum HCV RNA 51 elevated triglyceride levels 51 mCi m 2 51 liver histology 51 urinary N telopeptide 51 mg qd 51 #ug [001] 51 Target Lesion Revascularization TLR 51 systolic 51 PEG IFN 51 nonfatal stroke 51 ‰ ¥ 51 #.#m #.#m #.#m [003] 51 m3 h 51 pCR 51 myocardial infarction stroke 51 HIV RNA 51 hematologic toxicity 51 Ambulatory Blood Pressure 51 stage IIIb IV 51 laboratory abnormalities 51 flutamide 51 RLAI 51 rapid virologic response 51 Nephrol Dial Transplant 51 serum calcium levels 51 preintervention 51 hypercholesterolaemia 51 reperfusion therapy 51 #mL [001] 51 chlorthalidone 51 timepoints 51 Intra arterial 51 ritonavir boosted 51 atrioventricular block 51 OADs 51 systolic diastolic blood 51 titrated glipizide 51 abdominal pain flatulence 51 #mg BID [001] 51 hemodynamic parameters 51 progesterone receptor negative 51 median PFS 51 hypomagnesemia 51 chloride secretion 51 morphometric vertebral fractures 51 pulmonary exacerbation 51 cytopenias 51 mg/# h 50 baseline Hb 50 Doppler sonography 50 tricuspid 50 GFR 50 P ≤ 50 bronchoalveolar lavage 50 6 mercaptopurine 50 antihypertensive agents 50 artificial arteriovenous dialysis 50 apolipoprotein B 50 plasma glucose 50 CTEPH 50 blood Phe 50 Crohn Disease Activity 50 splenectomized 50 μg dl 50 Ejection Fraction 50 p = #.# [004] 50 mmol liter 50 intramuscularly 50 stage IIIB 50 left ventricular LV 50 azacytidine 50 DAPT 50 intracranial hemorrhage ICH 50 postoperative complication 50 uL 50 remifentanil 50 HbA1c 50 placebo dexamethasone 50 myocardial reperfusion 50 serum LDL cholesterol 50 male Wistar rats 50 K + ATPase 50 #.#/#.# mm Hg [002] 50 = #.#-#.# 50 Eur J Endocrinol 50 heterozygotes 50 ALVESCO 50 posttreatment 50 peginterferon alfa 2a 50 thyrotropin levels 50 thrombolytic therapy 50 μsec 50 nausea photophobia 50 SCFM 50 undetectable HBV DNA 50 SGRQ 50 ß = 50 Hb levels 50 rFSH 50 #.#V #.#V [001] 50 IELT 50 - -winger Colby Armstrong 50 doxazosin 50 APACHE II 50 symptomatic intracranial hemorrhage 50 peak VO2 50 % CI #.#-#.# [008] 50 mg/# hours 50 cardiogenic shock 50 somatostatin analog 50 pleural fluid 50 thoracoscopic lobectomy 50 reactive hyperemia 50 mg p = 50 isoprostane 50 minute gpm 50 ximelagatran 50 total cholesterol triglycerides 50 carotid artery stenosis 50 ventricular myocardium 50 3mg/kg 50 refractory NSCLC 50 Stent thrombosis 50 ^ sup 50 mmol kg 50 histologically confirmed 50 HGPIN 50 EDSS scores 50 alkaline phosphatase 50 epicardial 50 thyroid stimulating hormone TSH 50 elevated uric acid 50 eptifibatide 50 interquartile range IQR 50 radical nephrectomy 50 adefovir treated 50 -#.# mg dL [001] 50 gemcitabine cisplatin 50 neurodevelopmental impairment 50 CD4 + cell 50 serum sodium levels 50 statistically significant p = 50 COPD exacerbation 50 aldosterone antagonist 50 sirolimus eluting 50 pulmonary artery pressure 50 #.#-#.# [005] 50 lipid lowering agents 50 variceal hemorrhage 50 pipe diameters 50 dose atorvastatin 50 salmeterol fluticasone propionate 50 mg/m2 50 interleukin IL -6 50 hemodynamics 50 Ishak fibrosis score 50 iodixanol 50 mK 50 plasma creatinine 50 #ppm Cu 50 HbA1C levels 50 plasma HCV RNA 50 XIENCE V vs. 50 Retreatment 50 cis retinoic acid 50 renal insufficiency 50 metformin sulphonylurea 50 Qmax 50 glyburide 50 elevated LDH 50 onset diabetes mellitus 50 ATACAND 50 hypercalciuria 50 aged ≥ 50 mineral density 50 copies ml 50 Viread Emtriva Sustiva 50 dose colchicine 50 LS BMD 50 pulsatile 50 pyelonephritis 50 mso footer margin 50 log# reduction 50 PREZISTA r 50 PCa 50 antegrade 50 μg dose 50 vertebrobasilar 50 pT2 50 oral glucose tolerance 50 statistically significant p 50 radiotherapy RT 50 PREZISTA r arm 50 Wistar rats 50 dapagliflozin plus 50 hemoglobin concentration 50 lanreotide 50 somnolence headache 50 active comparator 50 reinfarction 50 metastatic malignant 50 plasma fibrinogen 50 ohm cm 50 ribavirin therapy 50 diuretic chlorthalidone 50 CR nPR 50 mOhm 50 splanchnic 50 recanalization 50 Peginterferon Alfa 2a 50 interferon alfa 50 idarubicin 50 erythrocyte sedimentation rate 50 subcutaneously injected 50 amoxicillin clavulanate 50 Cardiopulmonary bypass 50 Kaplan Meier analysis 50 platelet reactivity 50 nonresponders 50 elevated fasting glucose 50 pCi l 50 thyroxine 50 HCTZ 50 TIMP 50 tortuosity 50 pg g 50 systolic pressure